THE VITATEX iCTC PLATFORM HAS BEEN ACQUIRED BY APPLIED DNA SCIENCES.
We continue to offer products that analyze Invasive Circulating Tumor Cells (iCTCs)
in standard patient blood samples.
Technology
Our proprietary Cell Adhesion Matrix (CAM) technology enables isolation and analysis of metastasis- initiating tumor cells.
Diagnostic Applications
Applied DNA assays may benefit patients by early detection of aggressive disease, selection of the right drug and monitoring treatment.
Drug Development
Companies developing new cancer drugs can access new models of metastasis and assay services that improve patient selection and monitoring in clinical trials, and discover new drugs.